Dr. Debbie C. Thurmond is the new Director of the Arthur
Riggs Diabetes and Metabolism Research Institute at City of Hope. She completed
her Ph.D. studies in Biochemistry at the University of Iowa, and her awards
include the Trailblazer in Research Award from Indiana University in 2010 and
her endowed chairship in 2017. She maintains a highly-funded research program
and is an internationally awarded scholar serving on acclaimed advisory panels
in the fields of diabetes and obesity research. She currently serves as Chair
of the NIH study section Basic Mechanisms of Diabetes and Metabolism (BMDM), as
well as on multiple other Editorial boards and national/international grant
review panels. Her team’s research focus encompasses investigations into
SNARE-mediated vesicle trafficking events and cytoskeletal signaling as they
pertain to the causes of diabetes. Her group has discovered that diabetic
individuals harbor defects and deficiencies in certain vesicle trafficking
proteins, and is actively engaged in devising strategies to remediate these
defects.
Dr. Debbie C. Thurmond is the new Director of the Arthur
Riggs Diabetes and Metabolism Research Institute at City of Hope. She completed
her Ph.D. studies in Biochemistry at the University of Iowa, and her awards
include the Trailblazer in Research Award from Indiana University in 2010 and
her endowed chairship in 2017. She maintains a highly-funded research program
and is an internationally awarded scholar serving on acclaimed advisory panels
in the fields of diabetes and obesity research. She currently serves as Chair
of the NIH study section Basic Mechanisms of Diabetes and Metabolism (BMDM), as
well as on multiple other Editorial boards and national/international grant
review panels. Her team’s research focus encompasses investigations into
SNARE-mediated vesicle trafficking events and cytoskeletal signaling as they
pertain to the causes of diabetes. Her group has discovered that diabetic
individuals harbor defects and deficiencies in certain vesicle trafficking
proteins, and is actively engaged in devising strategies to remediate these
defects.